Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8697619rdf:typepubmed:Citationlld:pubmed
pubmed-article:8697619lifeskim:mentionsumls-concept:C0009324lld:lifeskim
pubmed-article:8697619lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:8697619lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:8697619lifeskim:mentionsumls-concept:C0103647lld:lifeskim
pubmed-article:8697619lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:8697619lifeskim:mentionsumls-concept:C0205269lld:lifeskim
pubmed-article:8697619lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:8697619pubmed:issue1lld:pubmed
pubmed-article:8697619pubmed:dateCreated1996-9-3lld:pubmed
pubmed-article:8697619pubmed:abstractTextWe analysed the clinical significance of ANCA in patients with ulcerative colitis. On either an indirect immunofluorescence assay or an ELISA with fixed neutrophils, 71% (25/35) of the patients were positive for ANCA. However, only half of them reacted with either cathepsin G or lactoferrin. Western blot assays revealed positive bands in 40% (10/25) of the antibody-positive patients. The sizes of the bands detected were approximately 58, 47, 44, 40, and 28 kD. No significant correlation was found between the ANCA positivity and various variables, i.e. disease activity, extent of lesion, or treatment of the disease. The anti-cathepsin G and 28-kD positivity, however, significantly correlated with a refractory type of ulcerative colitis.lld:pubmed
pubmed-article:8697619pubmed:languageenglld:pubmed
pubmed-article:8697619pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8697619pubmed:citationSubsetIMlld:pubmed
pubmed-article:8697619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8697619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8697619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8697619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8697619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8697619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8697619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8697619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8697619pubmed:statusMEDLINElld:pubmed
pubmed-article:8697619pubmed:monthJullld:pubmed
pubmed-article:8697619pubmed:issn0009-9104lld:pubmed
pubmed-article:8697619pubmed:authorpubmed-author:OkazakiTTlld:pubmed
pubmed-article:8697619pubmed:authorpubmed-author:NakaiMMlld:pubmed
pubmed-article:8697619pubmed:authorpubmed-author:MoriKKlld:pubmed
pubmed-article:8697619pubmed:authorpubmed-author:OzakiSSlld:pubmed
pubmed-article:8697619pubmed:authorpubmed-author:SumitaSSlld:pubmed
pubmed-article:8697619pubmed:authorpubmed-author:SobajimaJJlld:pubmed
pubmed-article:8697619pubmed:authorpubmed-author:OsakadaFFlld:pubmed
pubmed-article:8697619pubmed:issnTypePrintlld:pubmed
pubmed-article:8697619pubmed:volume105lld:pubmed
pubmed-article:8697619pubmed:ownerNLMlld:pubmed
pubmed-article:8697619pubmed:authorsCompleteYlld:pubmed
pubmed-article:8697619pubmed:pagination120-4lld:pubmed
pubmed-article:8697619pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:meshHeadingpubmed-meshheading:8697619-...lld:pubmed
pubmed-article:8697619pubmed:year1996lld:pubmed
pubmed-article:8697619pubmed:articleTitleAnti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type.lld:pubmed
pubmed-article:8697619pubmed:affiliationDepartment of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Japan.lld:pubmed
pubmed-article:8697619pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8697619pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8697619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8697619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8697619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8697619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8697619lld:pubmed